Proxy Votes Now

Home › Funds › EA Series Trust › Moonvest ETF

Moonvest ETF (MNVT) proxy voting record 2025-2026

Fund family: EA Series Trust · Filed by EA Series Trust (CIK 1592900) · SEC series S000101844

Ticker: MNVT (C000272159)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 76 with, 0 against, 0 abstentions (not counted as with management). Shareholder proposals: 0 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with EA Series Trust as a whole

The same two figures as EA Series Trust’s manager page (129,593 ballot items across 92 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEA Series TrustItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)100.0%7496.1%115,618
Backed environmental and social shareholder proposals at US companiesn/a013.7%2,882

Where this fund voted differently from most EA Series Trust funds

Each ballot item this fund voted is set against the votes of the other EA Series Trust funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most EA Series Trust funds on all 32 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 82.9% of this fund’s 76 such votes could be given a sector; the other 13 (17.1%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Health Care1900.0%
Technology1700.0%
Industrials1600.0%
Consumer Discretionary1100.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections500
Audit-related90
Say-on-Pay90
Capital Structure40
Compensation30
Other10
Shareholder Rights and Defenses10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
OSCAR HEALTH, INC.June 4, 2026$4M100
KOHL'S CORPORATIONMay 20, 2026$2M110
SAREPTA THERAPEUTICS, INC.June 4, 2026$2M90
IONQ, INC.June 16, 2026$1M40
REDWIRE CORPORATIONMay 20, 2026$1M60
ARRAY TECHNOLOGIES, INC.May 19, 2026$682,95560
RED CAT HOLDINGS INCJune 18, 2026$633,54370
NUSCALE POWER CORPORATIONMay 29, 2026$485,819110

Search this fund’s votes by company

77 ballot items at 9 meetings in 2025-2026. Download all votes (CSV)

About this fund’s record

In the 2025-2026 proxy season, Moonvest ETF (MNVT) voted at 9 shareholder meetings of 9 companies, on 77 ballot items in all. Where management made a recommendation, the fund followed it on 100.0% of the items and voted against it 0 times. It voted FOR the board's own proposals more often than EA Series Trust's funds as a whole (100.0% against 96.1%). It voted the same way as most EA Series Trust funds on every item where a comparison was possible.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of EA Series Trust’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.